Psilocybin and Spiritual Practice

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

February 28, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy
Interventions
DRUG

psilocybin

dose manipulation as described in the protocol and to which volunteers are blinded

BEHAVIORAL

Intensity of support for spiritual practice

Volunteers will be assigned to standard or high support, as described in the protocol

BEHAVIORAL

Number of sessions

Volunteers will be assigned to either 2 or 3 sessions, as described in the protocol

Trial Locations (1)

21224

Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Fetzer Institute

OTHER

collaborator

The CSP Fund of the San Francisco Foundation

UNKNOWN

lead

Johns Hopkins University

OTHER

NCT00802282 - Psilocybin and Spiritual Practice | Biotech Hunter | Biotech Hunter